KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Return on Capital Employed (2019 - 2025)

Adaptive Biotechnologies' Return on Capital Employed history spans 7 years, with the latest figure at 0.14% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 22.0% year-over-year to 0.14%; the TTM value through Dec 2025 reached 0.14%, up 22.0%, while the annual FY2025 figure was 0.13%, 19.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.14% at Adaptive Biotechnologies, up from 0.19% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.14% in Q4 2025 and bottomed at 0.42% in Q2 2024.
  • The 5-year median for Return on Capital Employed is 0.3% (2025), against an average of 0.29%.
  • The largest annual shift saw Return on Capital Employed dropped -15bps in 2024 before it grew 22bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.25% in 2021, then dropped by -6bps to 0.26% in 2022, then tumbled by -43bps to 0.38% in 2023, then increased by 5bps to 0.36% in 2024, then surged by 62bps to 0.14% in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Return on Capital Employed are 0.14% (Q4 2025), 0.19% (Q3 2025), and 0.29% (Q2 2025).